Home
About Us
About Us
Board of Directors
Scientific Advisory Board
Management Team
Careers
For Researchers
Paxalisib
EVT801
Collaborating with Kazia
Publications and Presentations
For Partners
Our Current Partners
What We Are Looking For
For Patients
Accessing Kazia Drug Candidates in Clinical Trials
Accessing Kazia Drug Candidates for Compassionate Use
Resources for Patients
For Investors
ASX Announcements
SEC Filings
Corporate Presentations
Annual Reports
Financial Reports
AGM
Investor Newsletters
Corporate Governance
Shareholder Services
Media Centre
Overview
Video
Coverage
Contact
Contact Us
Subscribe to email alerts
Heading &
Sub-heading can be edited through HQI
Home
>
For Investors
>
ASX Announcements
ASX Announcements
SEC Filings
Corporate Presentations
Annual Reports
Financial Reports
AGM
Investor Newsletters
Corporate Governance
Shareholder Services
ASX Announcements
Filter by Year:
2023
2022
2021
2020
2019
2018
29-Sep-2023
Acceptance of late-breaking abstract of PNOC022 data
11-Sep-2023
Change in substantial holding
31-Aug-2023
2023 Corporate Governance Statement
31-Aug-2023
Appendix 4G
31-Aug-2023
Appendix 4E and 2023 Annual Report
11-Aug-2023
Final Director's Interest Notice - Iain Ross
11-Aug-2023
Cleansing Notice - updated
11-Aug-2023
Cleansing Notice
11-Aug-2023
Application for quotation of securities - KZA
11-Aug-2023
Kazia announces change to Board of Directors
1
2
3
4
5
6
7
Next
